Spastic Equinovarus In Stroke Patients clinical trials

Explore recruiting spastic equinovarus in stroke patients clinical trials.

Recruiting spastic equinovarus in stroke patients studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Spastic Equinovarus In Stroke Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Exploratory, longitudinal study to define changes in muscle, tendon and neural properties after botuline neurotoxin type A (BoNT) treatment of spastic equinovarus in first-ever stroke patients: a pilot study

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

Spastic Equinovarus In Stroke Patients trials by city

Spastic Equinovarus In Stroke Patients in Toronto Spastic Equinovarus In Stroke Patients in Vancouver Spastic Equinovarus In Stroke Patients in Montreal Spastic Equinovarus In Stroke Patients in Calgary Spastic Equinovarus In Stroke Patients in Edmonton Spastic Equinovarus In Stroke Patients in Ottawa Spastic Equinovarus In Stroke Patients in Winnipeg Spastic Equinovarus In Stroke Patients in Quebec City Spastic Equinovarus In Stroke Patients in Hamilton Spastic Equinovarus In Stroke Patients in Kitchener Spastic Equinovarus In Stroke Patients in London Spastic Equinovarus In Stroke Patients in Halifax Spastic Equinovarus In Stroke Patients in New York Spastic Equinovarus In Stroke Patients in Los Angeles Spastic Equinovarus In Stroke Patients in Chicago Spastic Equinovarus In Stroke Patients in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease